Northwestern Mutual Wealth Management
MCRB icon

Northwestern Mutual Wealth Management’s Seres Therapeutics MCRB Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed – – 2448
2016
Q3 		$0 Buy
+1
New +$351 ﹤0.01% 2266

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Northwestern Mutual Wealth Management's MCRB Position: Q4 2016 in Review

Northwestern Mutual Wealth Management sold out of Seres Therapeutics (MCRB) in Q4 2016, closing a stake of 1 share.

Northwestern Mutual Wealth Management first reported a position in MCRB in Q3 2016 and held it in 1 quarter. The position peaked at $0 in Q3 2016. 89 funds tracked by Wall St. Rank hold MCRB as of Q4 2016.

  • Northwestern Mutual Wealth Management reported no remaining Seres Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1 Seres Therapeutics share in Q4 2016.
  • Northwestern Mutual Wealth Management first reported a position in Seres Therapeutics in Q3 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Seres Therapeutics position peaked at $0 in Q3 2016.
  • 89 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2016, filed 15 Feb 2017.